HHS bans Anthropic`s Claude AI tool
03 Mar 2026 //
FIERCE BIOTECH
Pharmas Stress Safety, Drug Access Amid Unfolding Middle East War
03 Mar 2026 //
FIERCE PHARMA
United Therapeutics` Phase 3 Win Tees Up Filing To Challenge J&J
03 Mar 2026 //
FIERCE BIOTECH
uniQure Provides Update on AMT-130 for Huntington’s Disease
03 Mar 2026 //
GLOBENEWSWIRE
Sanofi`s Rilzabrutinib Granted Orphan Drug Status In Japan
03 Mar 2026 //
PRESS RELEASE
FDA Fully Releases Clinical Hold On Intellia CRISPR Trials
03 Mar 2026 //
FIERCE BIOTECH
Roche`s Fenebrutinib Validates First BTK Inhibitor For MS
03 Mar 2026 //
GLOBENEWSWIRE
Emcure Partners with Roche on Nephrology, Transplant Care
03 Mar 2026 //
INDPHARMAPOST
Breckenridge Launches Pomalidomide Capsules
03 Mar 2026 //
PRESS RELEASE
Drugs In Development
Market Intel

Market Place
Sourcing Support